The Europe Smart Pulse Oximeters Market would witness market growth of 7.2% CAGR during the forecast period (2022-2028).
Traditional pulse oximetry analyzes arterial hemoglobin oxygen saturation and pulse rate using two wavelengths of light (red and infrared) sent through a finger and a photodetector. Extended analysis of the photo plethysmographic waveform; use of multiple wavelengths of light to quantify methemoglobin, carboxyhemoglobin, and total hemoglobin content in blood; and use of electronic processes to improve pulse oximeter signal processing during low signal-to-noise ratio conditions are just a few of the recent advances in pulse oximetry. These advancements have given pulse oximeters new clinical uses that will have an impact on patient monitoring and treatment and will propel the smart pulse oximetry market.
Patients with chronic obstructive pulmonary disease (COPD) may experience low blood oxygen levels. Pulse oximetry is used to evaluate peripheral blood oxygen saturation (SpO2) during the day using a spot check or continuously for one or two nights to determine nocturnal desaturation. Natural changes in SpO2 may be missed if samples are taken at this frequency.
Cardiovascular diseases (CVD) remain the leading cause of death in Europe, responsible for 45 percent of all deaths. More than 4 million Europeans die each year from cardiovascular disease (CVD), the most common of which is coronary heart disease (CHD) and stroke. Many more people are admitted to hospitals, and many more develop long-term disabilities that require lifelong treatment. CVD has significant economic consequences for Europe, in addition to human suffering. CVD is expected to cost the EU economy €210 billion per year, including direct health-care costs as well as non-health costs including lost productivity and informal care for CVD patients. Central and Eastern Europe (CEE/CIS) has the highest rate of cardiovascular disease mortality in the world. This has raised the necessity of smart pulse oximeters in the region.
The Germany market dominated the Europe Smart Pulse Oximeters Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $160.1 Million by 2028. The UK market is anticipated to grow at a CAGR of 6.3% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 8% during (2022 - 2028).
Based on Type, the market is segmented into Fingertip, Hand held, Wrist worn, and Pediatric. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Home Environment. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Smart Pulse Oximeters Market will Hit $2.4 Billion by 2028, at a CAGR of 7.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Masimo Corporation. Koninklijke Philips N.V., Medtronic PLC, Omron Corporation, Smiths Group PLC, Contec Medical Systems Co., Ltd., Meditech Equipment Co .,Ltd (Meditech Group), Nonin Medical, Inc., Promed Technology Co., Ltd., and Tenko Medical System Corp.
By Type
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
